February 2026

Thu, 02/26/2026 - 17:13

Ind-Swift Group Hiring Area Business Manager - Pharmacy graduates apply

To achieve sales targets and market share objectives in the assigned territory by effectively managing a team of Medical Representatives.

Thu, 02/26/2026 - 17:13

Career as Senior Executive in Analytical R&D at Sami-Sabinsa Group

Should have experience in the analysis of residual contaminants such as Pesticides, ETO, PAH, Tricyclazole, Chloramphenicol, residual solvents

Thu, 02/26/2026 - 17:12

Walk in drive for Production / IPQA at Aurobindo Pharma

Process instrumentation/ Break down activities/ Process Maintenance / LYO/ Calibrations.

Thu, 02/26/2026 - 17:12

Quality Control and Quality Assurance Jobs at Concord Biotech

Experience to perform analysis on HPLC instrument for raw material, Finished Products, In Process Sample.

Thu, 02/26/2026 - 15:45

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories

IQVIA Holdings Inc a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories.

Thu, 02/26/2026 - 15:36

India and Brazil Sign MoU to Boost Pharmaceutical Regulatory Cooperation

India and Brazil formalised a partnership to deepen cooperation in the regulation of pharmaceutical and medical products by signing a Memorandum of Understanding (MoU) between India’s Central Drugs Standard Control Organisation (CDSCO) and the Brazilian Health Regulatory Agency (ANVISA).

Thu, 02/26/2026 - 15:31

India Transitions to Td Vaccine Under National Immunization Programme

In a major step to strengthen the country’s immunization framework, Union Health Minister JP Nadda inaugurated the indigenously manufactured Tetanus and Adult Diphtheria (Td) vaccine at the Central Research Institute (CRI), Kasauli

Thu, 02/26/2026 - 15:24

Indian Pharma Majors Line Up to Launch Semaglutide Generics; Market Seen as Huge Opportunity

With the patent expiry of semaglutide in India scheduled for March 2026, several leading Indian pharmaceutical companies are preparing to launch generic versions of the widely used diabetes and weight-loss drug.

Thu, 02/26/2026 - 15:17

Novartis to Build New Radioligand Therapy Site in Denton, Texas, Expanding US Network

Novartis today announced plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing facility in Denton, Texas, as part of its broader strategy to expand advanced cancer treatment capabilities across the United States.